Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiromichi Shimizu

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|December 10, 2023
[Organoid-based therapy]Ryuichi Okamoto, Tomohiro Mizutani, Hiromichi Shimizu
Digestion|November 10, 2022
Development and Application of Regenerative Medicine in Inflammatory Bowel DiseaseRyuichi Okamoto, Tomohiro Mizutani, Hiromichi Shimizu
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 9, 2023
[Pathology and treatment of inflammatory bowel disease from the perspective of stem cells]Ryuichi Okamoto, Tomohiro Mizutani, Hiromichi Shimizu
Intestinal Research|July 30, 2019
Stem cell-based therapy for inflammatory bowel diseaseHiromichi Shimizu, Kohei Suzuki, Mamoru Watanabe, et al.
Modern Rheumatology Case Reports|May 15, 2024
A case of IgG4-related disease associated with ulcerative colitis that was successfully treated with a JAK inhibitorTomonao Tanaka, Satsuki Aochi, Masaaki Uehara, et al.
Cellular Microbiology|December 23, 2011
Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infectionTakeshi Haneda, Yuta Ishii, Hiromichi Shimizu, et al.
Inflammatory Bowel Diseases|February 10, 2026
Stricture dynamics and prognosis during biologic therapy in ileal Crohn's disease: a real-world cohortKento Takenaka, Ami Kawamoto, Shuji Hibiya, et al.
Intestinal Research|November 8, 2023
Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn's disease activity confirmed by balloon-assisted enteroscopyAmi Kawamoto, Kento Takenaka, Shuji Hibiya, et al.
Inflammatory Intestinal Diseases|October 9, 2025
Real-World Data on the Effectiveness of Ustekinumab and Risankizumab for Crohn's DiseaseRyo Morikawa, Toshimitsu Fujii, Akiko Tamura, et al.
Intestinal Research|March 20, 2025
Comparative short-term efficacy of upadacitinib versus tofacitinib for ulcerative colitis: a 24-week real-world study in JapanAkiko Tamura, Hiromichi Shimizu, Toshimitsu Fujii, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|December 10, 2023
[Organoid-based therapy]Ryuichi Okamoto, Tomohiro Mizutani, Hiromichi Shimizu
Digestion|November 10, 2022
Development and Application of Regenerative Medicine in Inflammatory Bowel DiseaseRyuichi Okamoto, Tomohiro Mizutani, Hiromichi Shimizu
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 9, 2023
[Pathology and treatment of inflammatory bowel disease from the perspective of stem cells]Ryuichi Okamoto, Tomohiro Mizutani, Hiromichi Shimizu
Intestinal Research|July 30, 2019
Stem cell-based therapy for inflammatory bowel diseaseHiromichi Shimizu, Kohei Suzuki, Mamoru Watanabe, et al.
Modern Rheumatology Case Reports|May 15, 2024
A case of IgG4-related disease associated with ulcerative colitis that was successfully treated with a JAK inhibitorTomonao Tanaka, Satsuki Aochi, Masaaki Uehara, et al.
Cellular Microbiology|December 23, 2011
Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infectionTakeshi Haneda, Yuta Ishii, Hiromichi Shimizu, et al.
Inflammatory Bowel Diseases|February 10, 2026
Stricture dynamics and prognosis during biologic therapy in ileal Crohn's disease: a real-world cohortKento Takenaka, Ami Kawamoto, Shuji Hibiya, et al.
Intestinal Research|November 8, 2023
Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn's disease activity confirmed by balloon-assisted enteroscopyAmi Kawamoto, Kento Takenaka, Shuji Hibiya, et al.
Inflammatory Intestinal Diseases|October 9, 2025
Real-World Data on the Effectiveness of Ustekinumab and Risankizumab for Crohn's DiseaseRyo Morikawa, Toshimitsu Fujii, Akiko Tamura, et al.
Intestinal Research|March 20, 2025
Comparative short-term efficacy of upadacitinib versus tofacitinib for ulcerative colitis: a 24-week real-world study in JapanAkiko Tamura, Hiromichi Shimizu, Toshimitsu Fujii, et al.
Pageof 6